ALBPS
Biophytis SA
European company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XPAR
-
Updated: -
Times are shown in GMT+1, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. The company's drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.Biophytis is a biotechnology company. It is engaged in the treatment of age-related illnesses and develops first-in-class drugs to treat degenerative illnesses associated with aging and treatment to restore muscular & visual functions.
EURONEXT:ALBPS
FR0012816825
EUR
Loading Comparison
Latest ALBPS News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News